L:NYSELoews Corporation Analysis
Data as of 2026-07-01 - not real-time
$113.21
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Loews Corp (L) is trading at $113.21, comfortably above its 20‑day (108.6), 50‑day (108.1) and 200‑day (105.7) simple moving averages, signaling a sustained bullish trend. The 14‑day RSI sits at 65, indicating momentum is strong but not yet in overbought territory. MACD is bullish with the line (1.54) above the signal (0.86) and a positive histogram, reinforcing upward pressure. Technical support sits near $103.38 while resistance clusters around $114.39, placing the current price just shy of the near‑term ceiling. Volume is on an increasing trend, adding conviction to the price move. The stock’s beta of 0.13 points to very low market‑wide volatility, and its 30‑day volatility of 18.5% is moderate for the sector. The Fear & Greed Index reads “Extreme Greed” (90.9), reflecting strong investor appetite.
On the valuation side, L’s trailing P/E of 14.4 is well below the industry average of 16.9, and the DCF‑derived fair value of $132 suggests a sizable upside. The price‑to‑book of 1.25 aligns with a modest premium to net assets, while the price‑to‑sales of 1.26 is reasonable for a diversified insurer. Dividend yield of 0.22% is modest but the payout ratio of just 3.2% signals ample capacity to maintain the quarterly payout. The balance sheet shows $6.5 B in cash against $8.9 B of debt, yielding a debt‑to‑equity of 45.6%, a level that the company’s steady operating cash flow ($2.6 B) comfortably supports. Operating margins of 11.8% and a ROE of 9.2% indicate solid profitability, though revenue growth of only 1.4% points to a mature business. Historical max drawdown of –8% and a low beta further temper downside risk. Taken together, the metrics paint a picture of a fundamentally sound, value‑oriented stock with modest upside potential and a sustainable dividend.
On the valuation side, L’s trailing P/E of 14.4 is well below the industry average of 16.9, and the DCF‑derived fair value of $132 suggests a sizable upside. The price‑to‑book of 1.25 aligns with a modest premium to net assets, while the price‑to‑sales of 1.26 is reasonable for a diversified insurer. Dividend yield of 0.22% is modest but the payout ratio of just 3.2% signals ample capacity to maintain the quarterly payout. The balance sheet shows $6.5 B in cash against $8.9 B of debt, yielding a debt‑to‑equity of 45.6%, a level that the company’s steady operating cash flow ($2.6 B) comfortably supports. Operating margins of 11.8% and a ROE of 9.2% indicate solid profitability, though revenue growth of only 1.4% points to a mature business. Historical max drawdown of –8% and a low beta further temper downside risk. Taken together, the metrics paint a picture of a fundamentally sound, value‑oriented stock with modest upside potential and a sustainable dividend.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance but still above key moving averages
- RSI indicating strong momentum without extreme overbought
- Increasing volume supporting the current trend
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap to DCF fair value
- Low beta and moderate volatility reducing downside risk
- Sustainable dividend with a very low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Diversified business model with stable cash generation
- Strong balance sheet and ability to service debt
- Consistent profitability and modest but reliable earnings growth
Key Metrics & Analysis
Financial Health
Revenue Growth1.40%
Profit Margin8.82%
P/E Ratio14.4
ROE9.22%
ROA1.90%
Debt/Equity45.60
P/B Ratio1.2
Op. Cash Flow$2.6B
Free Cash Flow$2.1B
Industry P/E16.9
Technical Analysis
TrendBullish
RSI65.4
Support$103.38
Resistance$114.39
MA 20$108.60
MA 50$108.14
MA 200$105.66
MACDBullish
VolumeIncreasing
Fear & Greed Index90.88
Valuation
Fair Value$132.09
GradeUndervalued
TypeValue
Dividend Yield0.22%
Risk Assessment
Beta0.13
Volatility18.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.